Hospital
Hca Health Services of Oklahoma INC
Hca Health Services of Oklahoma INC was paid $692K by Medicaid between Jan 2018 and Jan 2018, across 119 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoHCA HEALTH SERVICES OF OKLAHOMA INC
OKLAHOMA CITY, OK 73104
OKLAHOMA CITY, OK 73104
33aNPI1780631390assigned 05/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$692K
24GClaims14,004
24DCodes billed119
24AFirst – last monthJan 2018 – Jan 2018
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#55 of 75
Median peer was paid$3.66M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,004 | $692K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 1,809 | 1,778 | $253K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 591 | 573 | $128K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.2% | 777 | 774 | $63K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.5% | 540 | 506 | $45K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 282 | 275 | $31K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.5% | 54 | 30 | $17K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.3% | 350 | 349 | $16K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 48 | 48 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.5% | 30 | 30 | $11K |
| 80053 | Comprehensive metabolic panel | 1.3% | 856 | 771 | $9K |
| 85027 | 1.2% | 1,359 | 1,182 | $9K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 14 | 14 | $5K |
107 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 80 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 300 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 48 | $3K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 20 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 113 | $3K |
| 76770 | <1% | 51 | $3K | |
| 88142 | <1% | 122 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 57 | $3K |
| 87400 | <1% | 196 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 142 | $2K |
| 81001 | <1% | 704 | $2K | |
| 87430 | <1% | 158 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $2K |
| 88342 | <1% | 23 | $2K | |
| 72170 | <1% | 113 | $2K | |
| 87088 | <1% | 255 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 848 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $2K |
| 73590 | <1% | 64 | $2K | |
| 77072 | <1% | 19 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 28 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 107 | $1K |
| 87070 | <1% | 172 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 44 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 35 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 48 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $1K |
| 74019 | <1% | 87 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 37 | $1K |
| 84439 | <1% | 131 | $1K | |
| 83520 | <1% | 57 | $1K | |
| 81025 | <1% | 152 | $1K | |
| 72082 | <1% | 27 | $926.38 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 111 | $885.16 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 93 | $865.54 |
| 86140 | <1% | 167 | $841.60 | |
| 82803 | <1% | 24 | $771.84 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 110 | $729.31 |
| 82784 | <1% | 63 | $689.12 | |
| 82977 | <1% | 91 | $658.76 | |
| 87522 | Neg quan hep c or qual rna | <1% | 15 | $657.46 |
| 83605 | <1% | 59 | $642.69 | |
| 87799 | <1% | 18 | $608.86 | |
| 86665 | <1% | 32 | $552.60 | |
| 87040 | <1% | 53 | $524.00 | |
| 71045 | Radiologic examination, chest; single view | <1% | 61 | $514.67 |
| 87077 | <1% | 62 | $504.40 | |
| 80069 | <1% | 58 | $502.74 | |
| 84305 | <1% | 24 | $496.57 | |
| 80061 | Lipid panel | <1% | 39 | $492.78 |
| 73551 | <1% | 32 | $482.56 | |
| 94644 | <1% | 13 | $445.38 | |
| 82330 | <1% | 22 | $444.16 | |
| 74018 | <1% | 35 | $435.03 | |
| 86160 | <1% | 32 | $389.76 | |
| 84466 | <1% | 30 | $388.80 | |
| 82728 | <1% | 28 | $387.52 | |
| 85610 | <1% | 98 | $379.52 | |
| 83690 | <1% | 61 | $378.82 | |
| 87186 | <1% | 45 | $359.98 | |
| 85651 | <1% | 101 | $356.40 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $342.30 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 13 | $337.87 |
| 80197 | <1% | 32 | $334.80 | |
| 83519 | <1% | 22 | $317.73 | |
| 82248 | <1% | 59 | $300.31 | |
| 84145 | <1% | 12 | $299.31 | |
| 83735 | <1% | 48 | $265.20 | |
| 86255 | <1% | 27 | $243.00 | |
| 73130 | <1% | 12 | $238.00 | |
| 85730 | <1% | 40 | $237.90 | |
| 73070 | <1% | 17 | $236.80 | |
| 86664 | <1% | 16 | $232.95 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 17 | $231.37 |
| 83020 | <1% | 17 | $222.19 | |
| 84100 | <1% | 54 | $216.45 | |
| 86038 | <1% | 17 | $208.59 | |
| 82105 | <1% | 12 | $204.36 | |
| 83540 | <1% | 31 | $203.67 | |
| 73090 | <1% | 16 | $201.45 | |
| 86663 | <1% | 16 | $199.80 | |
| 73630 | <1% | 14 | $190.80 | |
| 86850 | <1% | 24 | $184.92 | |
| 85044 | <1% | 40 | $166.44 | |
| 83655 | <1% | 13 | $159.90 | |
| 80076 | <1% | 17 | $142.07 | |
| 82550 | <1% | 22 | $125.59 | |
| 83615 | <1% | 21 | $122.60 | |
| 85014 | <1% | 41 | $118.09 | |
| 82570 | <1% | 27 | $99.94 | |
| 82947 | <1% | 18 | $95.76 | |
| 84550 | <1% | 26 | $78.03 | |
| 84436 | <1% | 12 | $76.67 | |
| 86901 | <1% | 26 | $75.75 | |
| 86900 | <1% | 26 | $75.75 | |
| 86592 | <1% | 14 | $60.62 | |
| 84156 | <1% | 21 | $48.49 | |
| 85018 | <1% | 18 | $43.38 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 46 | $3.15 |
| 36000 | 0% | 35 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 63 | $0.00 |
| 36416 | 0% | 72 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 24 | $0.00 |
| 93320 | 0% | 14 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 213 | $0.00 |
| 93325 | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, DANIEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Rapides Healthcare System, L.L.C. | Alexandria, LA | $26.89M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.